Clazosentan Disodium is a selective endothelin receptor antagonist that acts on the ETA receptor to help prevent cerebral vasospasm in patients following aneurysmal subarachnoid hemorrhage. Pharmaceutical… Read more







Clazosentan Disodium is a selective endothelin receptor antagonist that acts on the ETA receptor to help prevent cerebral vasospasm in patients following aneurysmal subarachnoid hemorrhage. Pharmaceutical laboratories require high-quality reference standards of Clazosentan Disodium, along with its associated impurities, metabolites, and degradation products, to ensure the reliability of drug development and manufacturing processes. These compounds are essential for accurate impurity profiling and the validation of analytical methods, enabling researchers to maintain rigorous quality control standards. By utilizing these materials, including stable isotope labelled compounds for precise quantification in mass spectrometry, laboratories can effectively characterize the chemical profile of the active ingredient. This collection of reference materials supports the precise evaluation of potency, stability, and composition required throughout the pharmaceutical development lifecycle, ensuring adherence to the strict standards necessary for therapeutic consistency and safety.